GEL Q1 2026 Earnings EPS Misses Estimates Sharply Units Decline PROV Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech CISS Q3 2025 Earnings Losses Widen as Stock Declines 512 HCKT Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally CGON Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment